Using the lung adenocarcinoma (LUAD) dataset of The Cancer Genome Atlas (TCGA), Anlin Feng et al4 found that the overall survival (OS) of LUAD patients with high HMGB1 expression was poor, demonstrating that these novel next‐generation sequencing approaches and data can identify clinical biomarkers of cancer. Here, HMGB1 is linked to cancer.